EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,000 | -5.2% | 70,000 | 0.0% | 0.02% | -7.4% |
| Q2 2023 | $576,100 | +13.5% | 70,000 | 0.0% | 0.03% | +3.8% |
| Q1 2023 | $507,500 | -18.3% | 70,000 | 0.0% | 0.03% | -25.7% |
| Q4 2022 | $620,900 | -27.5% | 70,000 | 0.0% | 0.04% | -36.4% |
| Q3 2022 | $857,000 | +3.5% | 70,000 | 0.0% | 0.06% | +1.9% |
| Q2 2022 | $828,000 | -12.9% | 70,000 | +40.0% | 0.05% | +3.8% |
| Q1 2022 | $951,000 | -10.5% | 50,000 | +25.0% | 0.05% | -3.7% |
| Q4 2021 | $1,062,000 | +3.4% | 40,000 | +60.0% | 0.05% | -6.9% |
| Q3 2021 | $1,027,000 | -9.4% | 25,000 | +25.0% | 0.06% | -10.8% |
| Q2 2021 | $1,133,000 | +34.9% | 20,000 | 0.0% | 0.06% | +22.6% |
| Q1 2021 | $840,000 | +19.8% | 20,000 | +100.0% | 0.05% | +12.8% |
| Q4 2020 | $701,000 | – | 10,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |